Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Human Papilloma Virus 16, 18 E6 (HPV-16, HPV-18 E6) anticorps

HPV-16, HPV-18 E6 Reactivité: Human Papillomavirus 16 (HPV-16) ELISA, Coat Hôte: Souris Monoclonal HPV16-1295-HPV18-1297 unconjugated
N° du produit ABIN6933776
  • Antigène
    Human Papilloma Virus 16, 18 E6 (HPV-16, HPV-18 E6)
    Reactivité
    • 11
    • 3
    • 3
    • 1
    Human Papillomavirus 16 (HPV-16)
    Hôte
    • 15
    • 2
    Souris
    Clonalité
    • 15
    • 2
    Monoclonal
    Conjugué
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Inconjugué
    Application
    • 13
    • 13
    • 5
    • 3
    • 3
    • 2
    ELISA, Coating (Coat)
    Purification
    Purified by Protein A/G
    Immunogène
    HPV18 E6-β-galactosidase fusion protein
    Clone
    HPV16-1295-HPV18-1297
    Isotype
    IgG1 kappa
  • Indications d'application

    Positive Control: Human cervical cancer cells. Cervical tissue.

    Known Application: ELISA (For coating, order antibody without BSA), Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-80 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Date de péremption
    24 months
  • Antigène
    Human Papilloma Virus 16, 18 E6 (HPV-16, HPV-18 E6)
    Autre désignation
    HPV-16 E6 + HPV-18 E6 (Human Papilloma Virus 16/18)
    Classe de substances
    Viral Protein
    Sujet
    Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90 % of cervical cancers contain HPV DNA of the high risk types. Mutational analysis has shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.
    Poids moléculaire
    16/17kDa
Vous êtes ici:
Support technique